Lake Shore Gazette

Leading News Website

Rising Adoption of Compression Therapy Devices Market to Fuel Revenue Growth Through 2031

The Compression Therapy Devices Market Share is expected to witness a CAGR of 5.2% between 2021 (reaching US$ 3,232.3 Million). Vertical integration is the latest trend concerning the healthcare vertical. As such, drug manufacturers, hospital systems, wholesale distributors, PBMs (pharmacy benefit managers), medical insurers, and retail pharmacy outlets are into the formation of exclusive synergies all over the healthcare vertical.

According to a new market report published by Persistence Market Research “Global Market Study on Compression Therapy – Asia to Witness Highest Growth by 2020”, the global compression therapy market was valued at USD 2,377.8 million in 2014 and is expected to expand at a CAGR of 5.2% from 2014 to 2020, to reach USD 3,232.3 million by 2020.

Compression therapy is a procedure entailing the delivery of an external force to tired and aching legs and other relevant anatomical targets where compression is required for management. This therapy is used to treat venous and lymphatic diseases such as lower limb edema, venous eczema, deep vein thrombosis, and diabetic foot ulcers.

How About Looking Through The Sample Of Compression Therapy Devices Market Report? https://www.persistencemarketresearch.co/samples/3064

Some of the major players in the compression therapy market:

  • SIGVARIS.
  • BSN medical GmbH.
  • PAUL HARTMANN AG.
  • Julius Zorn GmbH.
  • ArjoHuntleigh.
  • THUASNE.
  • Smith & Nephew plc.
  • medi GmbH & Co. KG.
  • Medtronic plc.

How About Step-By-Step Insights To Compression Therapy Devices Market? Look Through The “Methodology” Employed! https://www.persistencemarketresearch.co/methodology/3064

Globally, the market for compression therapy is witnessing significant growth due to the increasing prevalence of diabetes, growth of the aging population, high incidence of sports injuries, rising awareness about various venous diseases, and the advanced features of compression therapy garments and devices.

However, inadequate reimbursement policies and the risk of complications associated with compression therapy systems inhibit the growth of the market. The global compression therapy market is anticipated to grow from an estimated USD 2,377.8 million in 2014 to USD 3,232.3 million by 2020 at a CAGR of 5.2% during the forecast period.

North America dominates the compression therapy market due to increasing numbers of sports injuries in the region. For instance, according to Safe Kids Worldwide, a global organization dedicated to preventing injuries in children, every year about 1.3 million cases of sports injuries among youngsters are registered in the U.S. Increasing prevalence of diabetes, aging population, and rising obesity are also supporting the growth of compression therapy market in North America.

Want To Keep A Tab On The Latest Findings In The Compression Therapy Devices Market? Purchase Our Compression Therapy Devices Market Report Now! https://www.persistencemarketresearch.com/checkout/3064

The compression therapy market in Europe is growing due to rising incidence of sports injuries in the region. According to the European Injury Database (IDB), approximately 4.5 million people above 15 years of age are treated in hospitals for sports injuries every year in the region. In addition, increasing the prevalence of diabetes and the growth of the aging population are also supporting the growth of the compression therapy market in Europe.

Asia is the fastest-growing region in the compression therapy market. According to the Asian Federation of Sports Medicine (AFSM), a part of International Federation of Sports Medicine (FIMS), on average 21,334 sports injuries occur every year in the region. Moreover, a growing aging population and increasing prevalence of diabetes are also supporting the growth of the compression therapy market in the region.

Access Trending Market Report

Sarcopenia Treatment Market @ https://www.prnewswire.com/news-releases/pharmacy-sarcopenia-treatment-market-to-showcase-healthy-expansion-at-4-2-cagr-during-2018-2026-persistence-market-research-810876590.html

About us:

Persistence Market Research, as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *